WuXi AppTec Boosts Biometrics with Pharmapace

04:38 EDT 13 May 2019 | CHEManager

China’s WuXi AppTec has acquired US clinical research services company Pharmapace, boosting its biometrics capabilities in Europe and the US. Financial details were not disclosed. Located in San Diego, California, Pharmapace provides biometrics services for all clinical trial phases, including clinical and statistical programming, data management, biostatistics, clinical data integration and medical writing for customers in Europe, North America and Asia.

Original Article: WuXi AppTec Boosts Biometrics with Pharmapace


More From BioPortfolio on "WuXi AppTec Boosts Biometrics with Pharmapace"

Quick Search


Relevant Topics

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...